The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $18,338,255 in first-year total cost, median $3,770,218.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-F (A1)]6
Most frequent institutions
- DANA-FARBER CANCER INST1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- ROSWELL PARK CANCER INSTITUTE CORP1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF MISSOURI-COLUMBIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Defining mechanisms of immunotherapy resistance in head and neck squamous cell carcinomas1U01DE029188-01 | BARBIE, DAVID AHADDAD, ROBERT I.UPPALURI, RAVINDRA | DANA-FARBER CANCER INST, MA | $4,259,203 | ZCA1 |
| 2019 | Mechanisms of Exosome Driven Immunoregulation of Cancer Progression1U01CA244452-01 | BLELLOCH, ROBERTFONG, LAWRENCE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $3,950,956 | ZCA1 |
| 2019 | Cytokine immunotherapies for melanoma1U01CA233096-01A1 | BOSENBERG, MARCUS W | YALE UNIVERSITY, CT | $3,810,235 | ZCA1 |
| 2019 | Human CD3epsilon co-potentiation to boost immunotherapy1U01CA244314-01 | GIL PAGES, DIANA | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $3,730,200 | ZCA1 |
| 2019 | Optimizing myeloma-specific immunity after autologous stem cell transplantation1U01CA244291-01 | HILL, GEOFFREY ROGER | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $1,785,659 | ZCA1 |
| 2019 | Reprograming the tumor microenvironment to overcome multiple primary and acquired immune resistance mechanisms in ovarian cancer1U01CA233085-01A1 | GAMBOTTO, ANDREAKOZBOR, DANUTA BODUNSI, KUNLE | ROSWELL PARK CANCER INSTITUTE CORP, NY | $802,002 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.